References
- Centers for Disease Control and Prevention. First travel-related case of 2019 novel coronavirus detected in United States. 2020 [cited 2020 Jul 29]. Available from: https://www.cdc.gov/media/releases/2020/p0121-novel-coronavirus-travel-case.html
- Centers for Disease Control and Prevention. Cases in the U.S. 2020 [cited 2020 Jul 29]. Available from: https://www.cdc.gov/media/releases/2020/p0121-novel-coronavirus-travel-case.html
- Muddasani S, Housholder A, Fleischer AB. An assessment of United States dermatology practices during the COVID-19 outbreak. J Dermatol Treat. 2020;31(5):436–438.
- Kutlu Ö, Güneş R, Coerdt K, et al. The effect of the “stay-at-home” policy on requests for dermatology outpatient clinic visits after the COVID-19 outbreak. Dermatol Ther. 2020;33(4):e13581.
- Gisondi P, Piaserico S, Conti A, et al. Dermatologists and SARS-CoV-2: the impact of the pandemic on daily practice. J Eur Acad Dermatol Venereol. 2020;34(6):1196–1201.
- Centers for Disease Control and Prevention. Cases by county. 2020 [cited 2020 Aug 15]. Available from: https://www.cdc.gov/coronavirus/2019-ncov/cases-updates/county-map.html
- Hollander JE, Carr BG. Virtually Perfect? Telemedicine for COVID-19. New Eng J Med. 2020;382(18):1679–1681.
- Teledermatology in the United States: an update in a dynamic era. Telemedicine eHealth. 2018;24(9):691–697.
- Leavitt ER, Kessler S, Pun S, et al. Teledermatology as a tool to improve access to care for medically underserved populations: a retrospective descriptive study. J Am Acad Dermatol. 2016;75(6):1259–1261.
- Warshaw EM, Hillman YJ, Greer NL, et al. Teledermatology for diagnosis and management of skin conditions: a systematic review. J Am Acad Dermatol. 2011;64(4):759–772. 21036419.
- Finnane A, Dallest K, Janda M, et al. Teledermatology for the diagnosis and management of skin cancer: a systematic review. JAMA Dermatol. 2017;153(3):319–327.